Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Proliferation of gynaecological scientific societies and their financial transparency: an Italian survey.

Vercellini P, Viganò P, Frattaruolo MP, Somigliana E.

BMJ Open. 2016 Jan 13;6(1):e008370. doi: 10.1136/bmjopen-2015-008370.

2.

The Relationship Between Industry and Pain Societies, Part 1: Demystification and Legitimization of Continuing Medical Education.

Darnall BD, Schatman ME.

Pain Med. 2015 Jul;16(7):1251. doi: 10.1111/pme.12828. Epub 2015 Jul 1. No abstract available.

3.

Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study.

Yeh JS, Austad KE, Franklin JM, Chimonas S, Campbell EG, Avorn J, Kesselheim AS.

PLoS Med. 2014 Oct 14;11(10):e1001743. doi: 10.1371/journal.pmed.1001743. eCollection 2014 Oct.

4.

Industry involvement in continuing medical education: time to say no.

Spithoff S.

Can Fam Physician. 2014 Aug;60(8):694-6, 700-3. English, French. No abstract available.

5.

Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.

De Ferrari A, Gentille C, Davalos L, Huayanay L, Malaga G.

PLoS One. 2014 Jun 30;9(6):e100114. doi: 10.1371/journal.pone.0100114. eCollection 2014.

6.

Assessment of professionalism in Iranian pharmacists.

Javadi M, Asghari F, Salari P.

J Med Ethics Hist Med. 2011 Jun 26;4:6. Print 2011.

7.

Ethics consultation on a gynecologic oncology service: an opportunity for physician education.

Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DC.

J Cancer Educ. 2011 Mar;26(1):183-7. doi: 10.1007/s13187-010-0154-2.

8.

Continuing medical education programs being placed under closer scrutiny.

Wilson B.

CMAJ. 2010 Oct 5;182(14):E683-4. doi: 10.1503/cmaj.109-3318. Epub 2010 Sep 7. No abstract available.

9.

A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.

Lieb K, Brandtönies S.

Dtsch Arztebl Int. 2010 Jun;107(22):392-8. doi: 10.3238/arztebl.2010.0392. Epub 2010 Jun 4.

10.

Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

Fonseca R, Richardson P, Giralt S, Lonial S, Rajkumar SV, Stewart AK, Bensinger W, Somlo G, Vescio R, Mikhael J, Reeder C, Tiedemann R, Tricot G, Rifkin R, Shaughnessy J, Munshi N, Raje N, Ghobrial I, Laubach J, Schlossman R, Treon S, Mahindra A, Avigan D, Rosenblatt J, Jagannath S, Niesvizky R, Landau H, Chen-Kiang S, Siegel DS, Zimmerman T, Mehta J, Vesole D, Rosen S, Hofmeister C, Lacy M, Dispenzieri A, Borrello I, Hayman SR, Kumar S, Buadi F, Dingli D, Russell S, Melissa Alsina MA, Fernandez H, Roy V, Pereira D, Stadtmauer E, Vij R, Jakubowiak A, Lentzsch S, Song K, Trudel S, Chen C, Reece D, Stewart D, Singhal S, Comenzo R, Gertz MA, Greipp PR, Durie B, Barlogie B, Anderson K, Dalton W, Coleman M, Novis S, Kyle RA.

Mayo Clin Proc. 2010 Feb;85(2):197-9; author reply 201-4. doi: 10.4065/mcp.2009.0559. No abstract available.

11.

Commercial influence and learner-perceived bias in continuing medical education.

Steinman MA, Boscardin CK, Aguayo L, Baron RB.

Acad Med. 2010 Jan;85(1):74-9. doi: 10.1097/ACM.0b013e3181c51d3f.

12.

Society of American Gastrointestinal and Endoscopic Surgeons(SAGES)statement on the relationship between professional medical associations and industry.

Society of American Gastrointestinal and Endoscopic Surgeons.

Surg Endosc. 2010 Apr;24(4):742-4. doi: 10.1007/s00464-009-0802-y. No abstract available.

13.

Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship.

McPartland JM.

PLoS One. 2009;4(3):e5092. doi: 10.1371/journal.pone.0005092. Epub 2009 Mar 31.

14.

The need for an institute of continuing health education.

Hébert PC, Stanbrook MB, Sibbald B, Flegel K, MacDonald N, Attaran A.

CMAJ. 2008 Mar 25;178(7):805-6, 809-810. doi: 10.1503/cmaj.080317. English, French. No abstract available.

15.

CME, physicians, and Pavlov: can we change what happens when industry rings the bell?

Lichter PR.

Trans Am Ophthalmol Soc. 2008;106:39-43; discussion 44-5.

16.

Rebuttal: Is CME a drug-promotion tool?: YES.

Steinman MA, Baron RB.

Can Fam Physician. 2007 Nov;53(11):1877, 1878-9. English, French. No abstract available.

17.

Rebuttal: Is CME a drug-promotion tool?: NO.

Marlow B.

Can Fam Physician. 2007 Nov;53(11):1877, 1878-9. English, French. No abstract available.

18.

Is continuing medical education a drug-promotion tool?: YES.

Steinman MA, Baron RB.

Can Fam Physician. 2007 Oct;53(10):1650-7. English, French. No abstract available.

19.

Is continuing medical education a drug-promotion tool?: NO.

Marlow B.

Can Fam Physician. 2007 Oct;53(10):1650-2, 1654-6. English, French. No abstract available.

20.

A hypertensive snow bird.

Lexchin J.

CMAJ. 2005 Nov 22;173(11):1357; discussion 1358. No abstract available. Erratum in: CMAJ. 2006 Jan 17;174(2):207.

Supplemental Content

Loading ...
Support Center